HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,008 | -83.6% | 52,558 | -84.5% | 0.02% | -81.0% |
| Q2 2023 | $12,262 | +108.7% | 339,963 | +121.0% | 0.10% | +104.1% |
| Q1 2023 | $5,876 | +6.2% | 153,852 | +58.2% | 0.05% | -38.8% |
| Q4 2022 | $5,533 | -99.9% | 97,248 | -1.8% | 0.08% | +56.9% |
| Q3 2022 | $3,914,000 | -44.5% | 98,983 | -38.2% | 0.05% | -40.7% |
| Q2 2022 | $7,052,000 | +38.3% | 160,279 | +25.3% | 0.09% | +34.4% |
| Q1 2022 | $5,099,000 | +129.6% | 127,868 | +131.5% | 0.06% | +178.3% |
| Q4 2021 | $2,221,000 | +65.6% | 55,232 | +71.7% | 0.02% | +15.0% |
| Q1 2021 | $1,341,000 | -1.1% | 32,161 | -37.7% | 0.02% | -25.9% |
| Q3 2020 | $1,356,000 | +4.1% | 51,617 | +6.3% | 0.03% | -20.6% |
| Q2 2020 | $1,302,000 | +171.8% | 48,563 | +79.7% | 0.03% | +277.8% |
| Q4 2019 | $479,000 | – | 27,032 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |